drugset / Trial / NCT06505941
Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS
Phase 1/2
Not yet recruiting
60 enrolled
Southeast University, China
Yinguan Biologics, Shenzheng · collabZhongda Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The object of this study is to observe the safety of umbilical cord mesenchymal stem cell therapy for acute respiratory distress syndrome, consisting with two phases.
Timeline
- Start
- 2024-07-20
- Primary completion
- 2025-11-20
- Completion
- 2027-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Umbilical Cord Mesenchymal Stem Cell | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | Umbilical Cord Mesenchymal Stem Cell | Cell therapy | 5e+06 cells/kg | Intravenous |
| Subject | Umbilical Cord Mesenchymal Stem Cell | Cell therapy | 1e+07 cells/kg | Intravenous |